Abeona Therapeutics

Abeona Therapeutics is a company listed under the stock ticker ABEO (US).

View the org chart displaying its 17 main executives

Most searched biographies at Abeona Therapeutics

• Vishwas Seshadri, Chief Executive Officer and Director
• Michael Amoroso, Chairman of the Board
• Christine Silverstein, Director

Popular executive movements at Abeona Therapeutics

• Madhav Vasanthavada, who was Vice President, Business Development, is promoted to Chief Commercial Officer  (posted on September 13 2023).

Create your alert
to follow the executive moves at Abeona Therapeutics.

Abeona Therapeutics has 1,865 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Abeona Therapeutics

• Abeona Therapeutics Provides Regulatory Update on Pz-cel
• Press Releases
• Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• Abeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA Inspections
• Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• Abeona Therapeutics Announces Progress Update on Pz-cel Biologics License Application (BLA)
• Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• Abeona Therapeutics Announces $50 Million Credit Facility
• Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• Abeona Therapeutics Announces FDA Accepts and Grants Priority Review for Pz-cel Biologics License Application (BLA)
• View more press releases Close

Social media about Abeona Therapeutics

• Abeona Therapeutics on Wikipedia, Google News & Yahoo Finance
• Abeona Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Leila Alland

Call Abeona Therapeutics at +1 214...

View the org chart

Register to receive your alert

Report an error